Kazuo Kotani

899 total citations
26 papers, 761 citations indexed

About

Kazuo Kotani is a scholar working on Surgery, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kazuo Kotani has authored 26 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Epidemiology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kazuo Kotani's work include Lipoproteins and Cardiovascular Health (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Kazuo Kotani is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Kazuo Kotani collaborates with scholars based in Japan. Kazuo Kotani's co-authors include Takashi Kanno, Masato Maekawa, Mitsuhisa Manabe, Akira Kondo, Fuyuki Kametani, Kazunori Saito, Hideaki Bujo, Yasushi Saitō, Masahiro Inoue and Kazuo Takahashi and has published in prestigious journals such as European Heart Journal, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Lipid Research.

In The Last Decade

Kazuo Kotani

26 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuo Kotani Japan 15 247 163 148 146 139 26 761
R Locher Switzerland 16 176 0.7× 277 1.7× 108 0.7× 159 1.1× 116 0.8× 32 857
Wim Verreth Belgium 9 153 0.6× 162 1.0× 56 0.4× 153 1.0× 129 0.9× 9 756
Sampath Parthasarathy United States 10 267 1.1× 257 1.6× 361 2.4× 207 1.4× 162 1.2× 12 1.1k
Г. Г. Коновалова Russia 14 166 0.7× 237 1.5× 202 1.4× 88 0.6× 105 0.8× 86 794
Hideaki Kurata Japan 16 215 0.9× 289 1.8× 233 1.6× 198 1.4× 64 0.5× 26 923
M. Ben-Naim Israel 13 212 0.9× 196 1.2× 300 2.0× 110 0.8× 113 0.8× 30 763
Julijana Stanimirović Serbia 12 116 0.5× 211 1.3× 88 0.6× 114 0.8× 115 0.8× 25 629
Xian-Mang Pan United States 15 343 1.4× 219 1.3× 382 2.6× 136 0.9× 111 0.8× 22 989
Y. Dabach Israel 15 387 1.6× 296 1.8× 325 2.2× 182 1.2× 115 0.8× 35 997
G. Hollander Israel 14 373 1.5× 279 1.7× 322 2.2× 177 1.2× 104 0.7× 30 954

Countries citing papers authored by Kazuo Kotani

Since Specialization
Citations

This map shows the geographic impact of Kazuo Kotani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuo Kotani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuo Kotani more than expected).

Fields of papers citing papers by Kazuo Kotani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuo Kotani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuo Kotani. The network helps show where Kazuo Kotani may publish in the future.

Co-authorship network of co-authors of Kazuo Kotani

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuo Kotani. A scholar is included among the top collaborators of Kazuo Kotani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuo Kotani. Kazuo Kotani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kotani, Kazuo, Amirhossein Sahebkar, Florina Andrica, et al.. (2015). Tibolone can decrease lipoprotein(a) concentrations in postmenopausal women: a systematic review and meta-analysis of controlled trials. European Heart Journal. 36. 286–286. 2 indexed citations
2.
Kotani, Kazuo, Jun Tashiro, Akira Miyazaki, et al.. (2015). Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus. Clinica Chimica Acta. 450. 145–150. 15 indexed citations
3.
Kotani, Kazuo, Seiji Adachi, Kokoro Tsuzaki, & Naoki Sakane. (2008). Relationship between serum preheparin lipoprotein lipase mass, plasma glucose and metabolic syndrome in older subjects. Age and Ageing. 38(1). 123–126. 2 indexed citations
4.
Maesawa, Chihaya, Satoshi Ogasawara, Akiko Yashima‐Abo, et al.. (2006). Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with cholelithiasis. Journal of Clinical Pathology. 59(3). 328–330. 21 indexed citations
5.
Ohnishi, Akihiro, et al.. (2004). Genetic and immunological analyses of patients with increased serum butyrylcholinesterase activity and its C5 variant form. Clinical Chemistry and Laboratory Medicine (CCLM). 42(9). 991–6. 10 indexed citations
6.
Miyazaki, Tetsuro, Kazunori Shimada, Osamu Satō, et al.. (2004). Circulating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease. Atherosclerosis. 179(1). 139–145. 44 indexed citations
7.
Kanno, Takashi, Masato Maekawa, Ikunosuke Sakurabayashi, et al.. (2004). Improved method for the immunological detection of malondialdehyde-modified low-density lipoproteins in human serum. Analytica Chimica Acta. 509(2). 229–235. 17 indexed citations
8.
Kondo, Akira, Hiroshi Morita, Hirotoshi Nakamura, et al.. (2003). Influence of fibrate treatment on malondialdehyde-modified LDL concentration. Clinica Chimica Acta. 339(1-2). 97–103. 13 indexed citations
9.
Yokota, Hiromitsu, Yoshiaki Hashimoto, Shigeo Okubo, et al.. (2002). Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD. Atherosclerosis. 162(2). 399–407. 24 indexed citations
10.
Kondo, Akira, Yoshinori Muranaka, Isao Ohta, et al.. (2001). Relationship between Triglyceride Concentrations and LDL Size Evaluated by Malondialdehyde-modified LDL. Clinical Chemistry. 47(5). 893–900. 90 indexed citations
11.
Shimomura, Takashi, et al.. (1999). Platelet Nitric Oxide Metabolites in Migraine. Cephalalgia. 19(4). 218–222. 62 indexed citations
12.
Maekawa, Masato, et al.. (1995). Genetic basis of the silent phenotype of serum butyrylcholinesterase in three compound heterozygotes. Clinica Chimica Acta. 235(1). 41–57. 21 indexed citations
13.
Kotani, Kazuo, et al.. (1994). Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1215(1-2). 121–125. 134 indexed citations
14.
Kotani, Kazuo, et al.. (1994). [Reestimation of aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio based on JSCC consensus method--changes of criteria for a differential diagnosis of hepatic disorders following the alteration from Karmen method to JSCC method].. PubMed. 91(2). 154–61. 18 indexed citations
15.
Maekawa, Masato, Kayoko Sudo, Dilip Dey, et al.. (1994). Genetic analysis of mutations in individuals with low serum cholinesterase activity.. SEIBUTSU BUTSURI KAGAKU. 38(3). 201–208. 1 indexed citations
16.
17.
Tokutake, Shoichi, et al.. (1993). Syntheses of modified 2-chloro-4-nitrophenyl β-maltopentaosides as useful substrates for assay of human alpha amylase. Carbohydrate Research. 238. 109–133. 9 indexed citations
18.
Tokutake, Shoichi, et al.. (1992). Syntheses of 2-Chloro-4-nitrophenyl .BETA.-D-Maltopentaosides with Bulky Modification and Their Application to the Differential Assay of Human .ALPHA.-Amylases.. Chemical and Pharmaceutical Bulletin. 40(9). 2531–2536. 6 indexed citations
19.
Kitagawa, Shuji, et al.. (1991). Asymmetry of membrane fluidity in the lipid bilayer of blood platelets: Fluorescence study with diphenylhexatriene and analogs. The Journal of Membrane Biology. 119(3). 221–227. 56 indexed citations
20.
Kotani, Kazuo, et al.. (1987). Inhibitory effects of long-chain alkyltrimethylammonium ions on aggregation of bovine platelets and the relation of their effects to Ca2+ mobilization. Biochimica et Biophysica Acta (BBA) - Biomembranes. 905(1). 75–80. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Locher Breakdown of academic impact, for papers by Wim Verreth Breakdown of academic impact, for papers by Sampath Parthasarathy Breakdown of academic impact, for papers by Г. Г. Коновалова Breakdown of academic impact, for papers by Hideaki Kurata Breakdown of academic impact, for papers by M. Ben-Naim Breakdown of academic impact, for papers by Julijana Stanimirović Breakdown of academic impact, for papers by Xian-Mang Pan Breakdown of academic impact, for papers by Y. Dabach Breakdown of academic impact, for papers by G. Hollander
Rankless by CCL
2026